Size of external genital organs and somatometric parameters among physically normal men younger than 40 years old

Urology ◽  
2002 ◽  
Vol 60 (3) ◽  
pp. 485-489 ◽  
Author(s):  
Evangelos Spyropoulos ◽  
Dimitrios Borousas ◽  
Stamatios Mavrikos ◽  
Athanasios Dellis ◽  
Michael Bourounis ◽  
...  
1959 ◽  
Vol 36 (2) ◽  
pp. 251-255 ◽  
Author(s):  
Richard S. Wilbur ◽  
Robert J. Bolt

1970 ◽  
Author(s):  
Robert T. Rubin ◽  
Richard H. Rahe ◽  
Brian R. Clark ◽  
Ransom J. Arthur

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Bougherara Hithem ◽  
Boukhechem Saïd ◽  
Aguezlane Abdelaziz ◽  
Benelhadj Khouloud ◽  
Aissi Adel

Background: Sticker sarcoma, also called venereal sarcoma or venereal lymphosarcomatosis, is a tumor of the external genital organs in females and males. In male animals the penis and foreskin (prepuce) are affected, in the female, it happens in vagina (vagina) and labia (vulva). The diagnosis of sticker sarcoma is based on the chronic discharge, the typical locations and the characteristic appearance of the tumor. Methods: We have relied on the treatment method on the complete surgical removal of all cancer cells that we can access. Results: After surgery, we notice recurrent tumors about six months after surgical treatment, indicating the need for other treatments in addition to surgery. Conclusion: Although spontaneous regressions of sticker sarcoma are documented (with permanent immunity), chemotherapy is the treatment of choice today. Irradiation should also be effective. If the tumor is only removed surgically, there is a high rate of recurrence, and this is what happened with the case that we treated, as the tumor reappeared after less than six months.


1965 ◽  
Vol 50 (1) ◽  
pp. 131-144 ◽  
Author(s):  
P. Mauvais-Jarvis ◽  
M. F. Jayle ◽  
J. Decourt ◽  
J. Louchart ◽  
J. Truffert

ABSTRACT Normal subjects and hirsute women with micropolycystic ovaries were treated with ethinyl-oestrenol + 3-methoxy-ethinyl-oestradiol (Lyndiol®), in view of studying the action of this compound on the production of androgens and on the urinary excretion of their metabolites. In normal men, the production of testosterone and the excretion of androsterone and aetiocholanolone are suppressed, whereas the excretion of other 17-ketosteroids and the production of dehydroepiandrosterone sulphate are unchanged. Moreover, the luteinizing hormone activity (LH) in plasma is depressed. It seems that the preparation inhibits specifically the testicular androgen production, by suppressing the hypothalamo-hypophyseal control of LH. Testosterone production and urinary 17-ketosteroid excretion are modified in the same way in women with Stein-Leventhal's syndrome. Physiopathological and therapeutical implications which come from these results are discussed.


1972 ◽  
Vol 70 (2) ◽  
pp. 342-350 ◽  
Author(s):  
M. A. Kirschner ◽  
D. W. R. Knorr

ABSTRACT An attempt was made to suppress production of androgens and oestrogens in normal men by administering large doses of exogenous androgens and corticoids. After 5 days of 40 mg fluoxymesterone qd, plasma testosterone concentrations decreased from 509 to 73 ng/100 ml (85%); on adding 8 mg qd of dexamethasone, there was a further decrease to 45 ng/100 ml. Androstenedione concentrations were decreased equally by fluoxymesterone and corticoids. To monitor the suppressive effects of exogenous steroids, urinary LH was followed serially by radioimmunoassay, and decreased to only 40% of control levels after 5 days of fluoxymesterone, with no further suppression noted on adding dexamethasone. Nanogram quantities of steroidal metabolites were not adsorbed by kaolin extraction of urine, thus enabling gonadotrophins (kaolin extract) and low-level steroids (supernate) to be measured in the same urine sample. Urinary oestrone and oestradiol excretion decreased during 5 days of fluoxymesterone, and continued to fall when dexamethasone was added. In no case was oestrone or oestradiol excretion, urinary LH or plasma androgens completely suppressed by large doses of fluoxymesterone alone, or in combination with large doses of dexamethasone.


1981 ◽  
Vol 138 (6) ◽  
pp. 470-473 ◽  
Author(s):  
Uriel Halbreich ◽  
Gregory Asnis ◽  
Donald Ross ◽  
Jean Endicott

SummaryDextroamphetamine (0.15 mg/kg) intravenously administered to a group of normal postmenopausal women induced a dysphoric reaction with drowsiness, annoyance, sadness and anger. Young normal men, receiving the same dosage, responded with elation of mood and alertness. It is suggested that age and hypoestrogenism may alter the behavioural response to amphetamine.


1979 ◽  
Vol 9 (2) ◽  
pp. 301-304 ◽  
Author(s):  
Peter V. Rabins ◽  
Phillip R. Slavney

SynopsisIn a study of 40 normal men it was found that self-ratings on variability of mood were positively correlated with self-ratings on hysterical traits. These results are similar to those found in normal women and lend support both to the validity of the concept of hysterical personality and to the idea that men and women experience fluctuations of mood in a similar way.


1972 ◽  
Vol 43 (3) ◽  
pp. 433-441 ◽  
Author(s):  
R. W. Marshall ◽  
M. Cochran ◽  
W. G. Robertson ◽  
A. Hodgkinson ◽  
B. E. C. Nordin

1. Diurnal variations in urine calcium oxalate and calcium phosphate activity products were observed in normal men and patients with recurrent calcium oxalate or mixed oxalate—phosphate renal stones. 2. Maximum and minimum calcium oxalate products were higher in the patients than in the controls, the difference being most marked in the patients with calcium oxalate stones. 3. Maximum and minimum calcium phosphate products expressed as octocalcium phosphate [(Ca8H2(PO4)6], brushite or hydroxyapatite, were significantly higher than normal in the patients with mixed stones but not in the patients with calcium oxalate stones. 4. The raised calcium oxalate products in the patients were due mainly to increased concentrations of Ca2+ ions; these, in turn, were due mainly to an increased rate of excretion of calcium. Raised calcium phosphate products were due mainly to hypercalciuria, combined with abnormally high urine pH values. 5. Patients with recurrent calcium stones appear to fall into two types: (1) patients with calcium oxalate stones associated with hypercalciuria, a normal or raised urine oxalate and a normal urine pH; (2) patients with mixed oxalate—phosphate stones associated with hypercalciuria, a normal or raised urine oxalate and a raised urine pH. 6. The implications of these findings in regard to treatment are discussed.


Sign in / Sign up

Export Citation Format

Share Document